Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus delayed epinephrine administration in pediatric septic shock
ISRCTN40192699Phase 4Completed
- Sponsor
- Udayana University
- Start
- Dec 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of epinephrine in septic shock (2 arms), sponsored by Udayana University. Primary endpoint: Ferritin. Started Dec 2019; status: completed.
02
Drugs
epinephrine
03
Conditions
septic shock
Beyond the preview
Go deeper on ISRCTN40192699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN40192699.